GENFIT
LIVE

Serial Number

76365742

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Jan 31, 2002

Add to watchlist:

No watchlists yet
View on USPTO

GENFIT Trademark

Serial Number: 76365742 • Registration: 2865973

GENFIT is a trademark filed by GENFIT on January 31, 2002. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (46 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

January 31, 2002

Registration Date

July 27, 2004

Published for Opposition

May 4, 2004

Goods & Services

Pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, infections, cancers and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes;[ veterinary pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, cancers, and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes; sanitary preparations for diagnosis and for acute and chronic care, namely, antibiotic, antibacterial, antiviral and antifungal agents for elimination or reduction of germs, bacteria, viruses and fungi;] chemical preparations for medical, pharmaceutical or[ veterinary] diagnostic use; enzymatic preparations for medical, pharmaceutical [or veterinary] use; biological preparations, namely, antibodies and fragments of antibodies for laboratories, diagnostics, and analytics for human[ and veterinary] medical diagnostic use; pharmaceutical preparations for the treatment of skin conditions, [medicated skin care preparation for pharmaceutical use; medicated sunburn preventing products, namely, creams, oils, lotions, gels, for pharmaceutical use; slimming medical preparations;] cultures of microorganisms for medical, pharmaceutical [and veterinary ]use; media for bacteriological cultures; nutrients for use in medical, pharmaceutical [and veterinary research;] cell preparations for medical, pharmaceutical [or veterinary use,] in particular for gene therapy and cell therapy; [kits consisting primarily of culture media, culture boxes, culture additives, and diagnostic reagents for the preparation of cells or for the selection of biologically active compounds for medical, pharmaceutical or veterinary laboratory testing, or for medical or veterinary diagnostic use; diagnostic and biological preparations and cultures of microorganisms and cells for clinical or medical laboratory use; reagents for medical, veterinary and diagnostic use, diagnosis products, namely,] reagents for medical [or veterinary use;] chemical and biological reagents for clinical or medical laboratory use;[ diagnostic preparations for clinical or medical laboratory use;] diagnosis reagents for medical[, veterinary] use[ and in vitro use in biochemistry,] clinical chemistry and microbiology[; dietetic substances, namely, dietary supplements and food supplements for medical use; dietetic foodstuffs adapted for medical use]

Providing an online electronic computer database in the field of medical and pharmaceutical information

Pharmaceutical research and development of new drug products for others; scientific, biological and medical research in the fields of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development of new drug products for others; scientific, biological and medical research in the field of pharmacology, analytical chemistry, biological and medical research in the field of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, chemical, biochemical and biotechnological analysis; basic and applied scientific research; technical research, namely screening and selection of molecules; validation of biological targets; development and validation of biological tests, cell tests, and genetic tests, identifying, characterizing, validating, and development biologically active molecules through the se of functional genomics; analysis of biological substances in biological fluids; technical consultation in the field of pharmaceuticals; legal services in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research and for the pharmaceutical industry; surveying and engineering; chemical analysis in the field of pharmacology; technical consultation in the field of pharmacology; consultation, not connected with the conduct of business, in the fields of scientific research and therapy; research and development of new pharmaceutical products for third parties; providing an online electronic computer database in the field of scientific information

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 29, 2024 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Mar 29, 2024 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 29, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 29, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 6, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 27, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 16, 2014 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 16, 2014 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 16, 2014 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 13, 2014 APRE
TEAS SECTION 8 & 9 RECEIVED
Jul 25, 2014 E89R
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 13, 2010 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 11, 2010 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 22, 2010 E815
REVIEW OF CORRESPONDENCE COMPLETE
Feb 20, 2009 CORV
PAPER RECEIVED
Feb 2, 2009 MAIL
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2004 R.PR
PAPER RECEIVED
May 10, 2004 MAIL
PUBLISHED FOR OPPOSITION
May 4, 2004 PUBO
NOTICE OF PUBLICATION
Apr 14, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2003 CNSA
PAPER RECEIVED
Oct 20, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2003 CRFA
NON-FINAL ACTION MAILED
Aug 27, 2003 CNRT
CASE FILE IN TICRS
Jul 16, 2003 CFIT
Sec. 1(B) CLAIM DELETED
Jul 9, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2003 CRFA
PAPER RECEIVED
Jul 9, 2003 MAIL
LETTER OF SUSPENSION MAILED
Jan 10, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2002 CRFA
PAPER RECEIVED
Nov 13, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2002 CRFA
ASSIGNED TO EXAMINER
Oct 17, 2002 DOCK
NON-FINAL ACTION MAILED
May 8, 2002 CNRT
PAPER RECEIVED
Apr 29, 2002 MAIL
ASSIGNED TO EXAMINER
Apr 19, 2002 DOCK